Michael Secora - Net Worth and Insider Trading
Michael Secora Net Worth
The estimated net worth of Michael Secora is at least $11 Million dollars as of 2024-12-28. Michael Secora is the CFO of Recursion Pharmaceuticals Inc and owns about 1,499,631 shares of Recursion Pharmaceuticals Inc (RXRX) stock worth over $11 Million. Details can be seen in Michael Secora's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Secora has not made any transactions after 2024-11-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Secora
Michael Secora Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Secora owns 1 companies in total, including Recursion Pharmaceuticals Inc (RXRX) .
Click here to see the complete history of Michael Secora’s form 4 insider trades.
Insider Ownership Summary of Michael Secora
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RXRX | Recursion Pharmaceuticals Inc | 2024-11-13 | Chief Financial Officer |
Michael Secora Latest Holdings Summary
Michael Secora currently owns a total of 1 stock. Michael Secora owns 1,499,631 shares of Recursion Pharmaceuticals Inc (RXRX) as of November 13, 2024, with a value of $11 Million.
Latest Holdings of Michael Secora
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RXRX | Recursion Pharmaceuticals Inc | 2024-11-13 | 1,499,631 | 7.39 | 11,082,273 |
Holding Weightings of Michael Secora
Michael Secora Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Secora has made a total of 17 transactions in Recursion Pharmaceuticals Inc (RXRX) over the past 5 years, including 0 buys and 17 sells. The most-recent trade in Recursion Pharmaceuticals Inc is the sale of 30,000 shares on November 13, 2024, which brought Michael Secora around $229,500.
Insider Trading History of Michael Secora
- 1
Michael Secora Trading Performance
Michael Secora Ownership Network
Michael Secora Owned Company Details
What does Recursion Pharmaceuticals Inc do?
Who are the key executives at Recursion Pharmaceuticals Inc?
Michael Secora is the Chief Financial Officer of Recursion Pharmaceuticals Inc. Other key executives at Recursion Pharmaceuticals Inc include director & 10 percent owner & Chief Executive Officer Christopher Gibson , President and COO Tina Marriott Larson , and Chief Corp. Dev. Officer Shafique Virani .
Recursion Pharmaceuticals Inc (RXRX) Insider Trades Summary
Over the past 18 months, Michael Secora made 16 insider transaction in Recursion Pharmaceuticals Inc (RXRX) with a net sale of 678,124. Other recent insider transactions involving Recursion Pharmaceuticals Inc (RXRX) include a net sale of 465,440 shares made by Blake Borgeson , a net sale of 1,232,842 shares made by Christopher Gibson , and a net sale of 91,000 shares made by Tina Marriott Larson .
In summary, during the past 3 months, insiders sold 231,788 shares of Recursion Pharmaceuticals Inc (RXRX) in total and bought 0 shares, with a net sale of 231,788 shares. During the past 18 months, 2,841,547 shares of Recursion Pharmaceuticals Inc (RXRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,841,547 shares.
Recursion Pharmaceuticals Inc (RXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Recursion Pharmaceuticals Inc Insider Transactions
Michael Secora Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Secora. You might contact Michael Secora via mailing address: C/o Recursion Pharmaceuticals, 41 S. Rio Grande Street, Salt Lake City Ut 84101.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
